Experimental Breast Cancer Models: Preclinical Imaging Perspective

Basit Öğe Kaydı
dc.authoridKorkmaz, Ulku/0000-0002-7155-7610
dc.authorwosidKorkmaz, Ulku/AAJ-4430-2020
dc.contributor.authorKorkmaz, Ulku
dc.contributor.authorUstun, Funda
dc.date.accessioned2024-06-12T10:55:15Z
dc.date.available2024-06-12T10:55:15Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: Breast cancer is the leading cause of cancer in women. 13% of breast cancer patients are at a distant stage and mortality is due to metastases rather than primary disease. The unique genetic structure and natural process of breast cancer make it a very suitable area for targeted therapies. Experimental tumor models are validated methods to examine the pathogenesis of cancer, the onset of the neoplastic process and progression. Objective: This study aims to review the current literature on experimental breast cancer models and to bring a new perspective to the use of these models in teranostic preclinical studies in terms of the imaging. Methods: Search for relevant literature from academic databases using keywords (Breast cancer, theranostic, preclinical imaging, tumor models, animal study, and tailored therapy) was conducted. The full text of the articles was reached and reviewed. Current scientific data has been reevaluated and compiled according to subtitles. Results and Conclusion: The development of animal models for breast cancer research has been done in the last century. Imaging methods used in breast cancer are used for tumor localization, quantification of tumor mass, imaging of genes and proteins, evaluation of tumor microenvironment, evaluation of tumor cell proliferation and metabolism and treatment response evaluation. Since human breast cancer is a heterogeneous group of diseases in terms of genetics and phenotype; it is not possible for a single model to adequately address all aspects of breast cancer biology. Considering that each model has advantages and disadvantages, the most suitable model should be chosen to verify the thesis of the study.en_US
dc.identifier.doi10.2174/1874471013666200508080250
dc.identifier.endpage14en_US
dc.identifier.issn1874-4710
dc.identifier.issn1874-4729
dc.identifier.issue1en_US
dc.identifier.pmid32384044en_US
dc.identifier.scopus2-s2.0-85103992829en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage5en_US
dc.identifier.urihttps://doi.org/10.2174/1874471013666200508080250
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19356
dc.identifier.volume14en_US
dc.identifier.wosWOS:000641557600003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBentham Science Publ Ltden_US
dc.relation.ispartofCurrent Radiopharmaceuticalsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast Canceren_US
dc.subjectTheranosticen_US
dc.subjectPreclinical Imagingen_US
dc.subjectTumor Modelsen_US
dc.subjectAnimal Studyen_US
dc.subjectTailored Therapyen_US
dc.titleExperimental Breast Cancer Models: Preclinical Imaging Perspectiveen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu